Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

Autor:	Rashidghamat, Ellie, Kadiyirire, Tendai, Ayis, Salma, Petrof, Gabriela, Liu, Lu, Pullabhatla, Venu, Ainali, Chrysanthi, Guy, Alyson, Aristodemou, Sophia, McMillan, James R., Ozoemena, Linda, Mee, John, Pramanik, Rashida, Saxena, Alka, Nuamah, Rosamund, de Rinaldis, Emanuele, Serrano, Sonia, Maurin, Clarisse, Martinez-Queipo, Magdalena, Lwin, Su M., Ilic, Dusko, Martinez, Anna, Dazzi, Francesco, Slaper-Cortenbach, Ineke, Westinga, Kasper, Zeddies, Sabrina, van den Broek, Marcel, Onoufriadis, Alexandros, Mellerio, Jemima E., McGrath, John A.
Zdroj:	In Journal of the American Academy of Dermatology August 2020 83(2):447-454
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect